CTS Rotea Counterflow Centrifugation System
Successful processing and manufacturing in cell and gene therapy workflows is essential to the efficacy of the product. Autologous cell and gene therapy workflows involve isolating cells from an individual, engineering the cells, expanding and concentrating them, and infusing them back into the patient. Certain steps in these workflows could benefit from optimized automation to decrease hands-on time and the cost of the cell manufacturing process.
Download the application note to learn more about a closed cell processing system developed for small-batch cell therapy manufacturing, courtesy of Thermo Fisher Scientific.
